Thymus-related Myasthenia Gravis. Multimodal Therapy and Follow-up

Over the last 30 years Myasthenia Gravis (MG) has become amenable to successful treatment, primarily from the remarkable advances in our understanding of the biology of neuromuscular transmission and of pathogenic processes underlying the disorder [1, 2, 3, 4, 5]. With treatment, today, most patients can expect to lead normal or nearly normal lives. Some cases of MG may go into remission temporarily, and muscle weakness may disappear so that medications can be discontinued.